VALEANT PHARMACEUTICALS INTERNATIONAL
VALEANT PHARMACEUTICALS INTERNATIONAL
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: VRX
ISIN: CA91911K1021

VRX Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) Investors

  • 55
VRX Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) Investors

PR Newswire

BOSTON, March 30, 2020 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) that it is filing legal claims against the company on behalf of investors.

The company has recently agreed to settle a shareholder lawsuit filed against it by investors for over $1.2 billion dollars.

Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) investors that purchased between January 4, 2013 and March 15, 2016 are urged to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit Settlement website or call 1-800-934-2921 to speak to someone about your case. Your legal rights will be affected whether you act or do not act. If you do not act, you may permanently forfeit your right to recover on this claim.

The shareholder lawsuit stemmed from investor's allegations of US securities law violations committed by Valeant Pharmaceuticals Intl (NYSE:VRX) management that led to significant losses to investors. The lawsuit alleged that Valeant Pharmaceuticals Intl (NYSE:VRX) may have improperly used a pharmacy network to artificially increase sales for their drugs.

In February 2016, Valeant Pharmaceuticals Intl (NYSE:VRX) announced it would restate its financial results, citing issues with revenue recognition stemming from sales from a specific pharmacy network. In December 2019, the company agreed to pay over $1.2 billion to settle the shareholder lawsuit that stemmed from the above allegations.

Valeant Pharmaceuticals (NYSE: VRX), now Bausch Health Companies (NYSE: BHC) investors that purchased between January 4, 2013 and March 15, 2016 are urged to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit Settlement website or call 1-800-934-2921 to find out if you have a claim.

Receive alerts about potential class action lawsuits that may affect you by visiting the Class Action Lawsuit Center website.

Kyros Law specializes in a wide range of complex litigation, mass torts, and corporate governance matters, including the representation of whistleblowers, shareholders and consumers in securities fraud, false claims act and class actions. Our lawyers have been responsible for recovering hundreds of millions of dollars for our clients throughout the United States, Africa, Asia and Europe. Visit our website to learn more about our firm.

Cision View original content:http://www.prnewswire.com/news-releases/vrx-investor-alert-kyros-law-is-filing-legal-claims-on-behalf-of-valeant-pharmaceuticals-nyse-vrx-now-bausch-health-companies-nyse-bhc-investors-301031622.html

SOURCE Kyros Law

PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.